This message was sent to ##Email##
|
|
|
|
|
| |
ADAA
ADAA Welcomes Our New Board President, Beth Salcedo, MD
ADAA is pleased to announce that Mary E. (Beth) Salcedo, MD has assumed the role of President of the ADAA Board of Directors (BOD) effective Jan. 1, 2018. Dr. Salcedo will serve a two-year term.
Dr. Salcedo succeeds Karen L. Cassiday, PhD, who served as ADAA BOD President from 2015-2017. Dr. Cassiday will now serve as Immediate Past Board Chair.
"I am both honored and humbled to have been chosen to serve as Board President of such a wonderful organization. I appreciate ADAA's confidence in me and will work hard to serve the board and the membership. It has been a pleasure working with Karen over the last few years and I so appreciate the time she spent in her role as President to ensure that I was kept apprised of all the happenings at ADAA. I am also extremely grateful to have such an impressive and strong staff at ADAA who work tirelessly to support our mission, and I look forward to working hard alongside them to further the causes of our great organization," says Beth Salcedo, MD. Read the full announcement here.
Join Us for the 2018 ADAA Conference
As you begin to make plans for the New Year, ADAA encourages you to "think spring" and Washington, D.C.! Let's share, learn and innovate together at the 2018 ADAA Conference (April 5-8).
The ADAA conference is the professional hub for clinicians and researchers in the field of anxiety and depression, and related disorders who want to share, learn, innovate and advance the field in meaningful ways. It all starts with a compelling Opening Keynote and the Jerilyn Ross Lecture. The conference also features Master Clinician Sessions, and Timely Topics for Clinicians as well as the 21st Annual Scientific Research Symposium and the 4th Annual Clinical Practice Symposium. The online program will be available soon. Register for the conference today!
ADAA Professional Webinars
ADAA offers a variety of webinars for mental health professionals. From live one-hour interactive events, to recorded webinars and now specially priced recorded webinar bundles (see below). Earn 1 CE credit for most webinars. Most ADAA professional webinars offer CE credits. CE credits area approved by APA, NBCC, CAMFT and New York State Education Department's State Board for Social Work. View a complete listing of all upcoming live webinars.
Haven't contributed yet to ADAA's 2018 Fund the Future: Early Career Professional Program? There's still time to support this vital educational program. Thank you for your support!
|
As 2017 comes to a close, ADAA would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of Anxiety and Depression Insights a look at the most accessed articles from the year. Our regular publication will resume Tuesday, Jan. 9.
|
Medscape
From Oct. 10: Midday bright white light therapy may be effective for patients with bipolar depression, new research suggests. In the study, published Oct. 3 in the American Journal of Psychiatry, this treatment approach resulted in a better antidepressant response compared to exposure to dim red light in patients with bipolar disorder.
READ MORE
Science Daily
From Sept. 26: Patients with major depressive disorder have increased brain levels of a marker of microglial activation, a sign of inflammation, according to a new study. Scientists have found that the increase in the inflammatory marker was present specifically in patients with MDD who were experiencing suicidal thoughts, pinning the role of inflammation to suicidality rather than a diagnosis of MDD itself.
READ MORE
News-Medical
From March 21: The journal NeuroRegulation recently published the results of a scientific paper demonstrating for the first time that combined neurofeedback and heart rate variability training may have a "robust effect" on improving symptoms of anxiety and depression. According to the study, these treatments may provide an effective, non-pharmaceutical intervention to reduce symptoms of anxiety and depression.
READ MORE
News-Medical
From June 20: Early life stress encodes lifelong susceptibility to stress through long-lasting transcriptional programming in a brain reward region implicated in mood and depression, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 15 in the journal Science.
READ MORE
| |
MISSED AN ISSUE OF ANXIETY AND DEPRESSION INSIGHTS? VISIT AND SEARCH THE ARCHIVE TODAY. |
Newsweek
From Aug. 29: Google users can now easily screen themselves for depression. Users who search key terms such as "depression" and "clinical depression" have immediate access to the PHQ-9 test, a self-assessment tool that allows people to gauge their mental health and identify whether they're exhibiting common symptoms of depression.
READ MORE
Science Daily
From Sept. 5: A small pilot study has indicated that neurofeedback — where patients concentrate on modifying their own brainwave patterns — has potential to treat many of the 100 million people worldwide who suffer from treatment-resistant depression. This is the first time that neurofeedback has been shown to improve both individual symptoms and overall recovery in TRD.
READ MORE
TIME
From Jan. 10: Exercise isn't a cure for depression, but being active has been shown to alleviate some symptoms of depression in both teens and adults. Depending on the severity of the mood disorder, it could go a long way toward helping problems like negativity and rumination. Scientists are now investigating if the same benefits might apply to young children, an age group with increasing cases of depression. The report was published in the journal Pediatrics.
READ MORE
Psych Central
From Jan. 24: New research suggests that estrogen levels play a factor in whether a woman will develop post-traumatic stress disorder. Experts believe that low estrogen levels may make women more susceptible to the development of PTSD at some points in their menstrual cycles or lifetimes. Conversely, high estrogen levels may be protective.
READ MORE
Healio
From March 7: Recent findings identified depression symptom clusters that may be useful to clinicians when choosing an antidepressant treatment. To assess efficacy of antidepressants for depression symptom groups, researchers used patient-reported data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial (n = 4,039) to determine symptom clusters in a depressive symptom checklist.
READ MORE
Psych Central
From Feb. 14: New research finds that cognitive behavioral therapy actually changes key brain structures that are involved in processing and regulating emotions. The finding helps to explain the success of CBT for anxiety disorders. Remediation of social anxiety is an important accomplishment as anxiety in social situations is not a rare problem.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
